Edwards Lifesciences first-quarter profit beats estimates on heart devices strength [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
The California-based company now expects annual sales growth to be at the higher end of its 8% to 10% forecast. Edwards makes transcatheter aortic valve replacement (TAVR) devices and competes with Abbott Laboratories , Boston Scientific and Medtronic Sales of Edwards' TAVR devices rose 6% to $1 billion in the first quarter while revenue at $1.6 billion beat analysts' estimates of $1.57 billion. On an adjusted basis, the company reported a profit of 66 cents per share, above average analysts' estimates of 64 cents, as per LSEG data. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up Reporting by Pratik Jain in Bengaluru; Editing by Sriraj Kalluvila Our Standards:
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- 3 Reasons to Buy AbbVie Stock on the Dip [Yahoo! Finance]Yahoo! Finance
- Implantable Medical Device Market To Reach USD 218.1 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- QuidelOrtho names Brian Blaser as CEO [Seeking Alpha]Seeking Alpha
- BrioHealth wins FDA nod to trial BrioVAD ventricular assist device [Yahoo! Finance]Yahoo! Finance
- Global RTD Beverages Market Research 2024-2031: Increasing Focus on Health and Wellness, Rising Demand for Clean-Label Products, Product Premiumization [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/2/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/30/24 - Form 4
- ABT's page on the SEC website